choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Mirapex

Mirapex Newsletter
  • COLUMNIST: Tips and Treatments for Restless Leg Syndrome 30 Jul 2025 22:30 GMT

    drugs including antinausea drugs, antipsychotic drugs, some antidepressants, and cold and allergy medications … are ropinirole (Requip), pramipexole (Mirapex), and the transdermal … medicines have become a first-choice drug treatment option for most doctors

  • Parkinson’s drug found to be effective in treating depression 30 Jun 2025 11:55 GMT

    … , the trial (ISRCTN84666271) found pramipexole to be … treatment-resistant depression when added to ongoing antidepressant medication. Pramipexolemedication is commonly sold under the brand name Mirapex … the prestigious Clinical Trials Arena Excellence Awards …

  • Do you have restless legs syndrome? Treatment advice has changed 07 Mar 2025 21:59 GMT

    … to clinical trials, longitudinal studies, and the experience of doctors in … showing the drugs cause augmentation. This affects medications including the drugs pramipexole (Mirapex®) and … advice for RLS covers existing treatments that help many people …

  • Sunosi interactions: Alcohol, medications, and other factors 07 Oct 2024 12:48 GMT

    … during treatment. Dopaminergic drugs Dopaminergic drugs are drugs that … ) pramipexole (Mirapex) ropinirole (Requip) Steps you or your doctor may … with supplements, foods, vaccines, or even lab tests … as your doctor prescribes. Disclaimer: Medical News Today …

  • Positive Phase 3 Results for First-in-Class Parkinson's Med 10 Oct 2024 13:51 GMT

    … 3 TEMPO trials. In the TEMPO-3 trial, topline … for a once-daily drug." What distinguishes … oral dopamine agonists such as pramipexole (Mirapex) [and] ropinirole (Requip … medical meetings and used to support regulatory submissions of tavapadon as treatment

  • I'm a pharmacist - beware of these five drugs that send your sex drive soaring and could turn you into a cheater 05 Aug 2024 20:37 GMT

    … analysis of the FDA Adverse Reporting System and available medical literature found … website: 'Unlike many other antidepressants that can dampen sexual desire … few risky decisions.'  Pramipexole - Mirapex A common drug used to treat restless …

  • USPTO Publishes Drug Patent and Exclusivity Study Report 25 Jun 2024 01:18 GMT

    … with the Food and Drug Administration (FDA) and in response … of innovative medicines and the availability of generic drugs and … and other public FDA databases for 25 drug products (representing 13 … some cases (e.g., MIRAPEX), newer methods of use protected …

  • Parkinson's Disease Diagnosis and Treatment Market Size to Worth USD 14.36 Bn by 2032 28 May 2024 15:00 GMT

    … are Requip (ropinirole), Mirapex (pramipexole), Apokyn (apomorphine), … doctors begin treatment sooner. Starting treatment … to leading pharmaceutical companies, biotechnology firms, … treatment. Approval processes for new drugs, medical devices, and treatment

  • Biotech Industry Veterans Jeff Jonas and Al Robichaud Join Cure Ventures as Partners 08 Jan 2024 12:10 GMT

    … and support of medicines such as Mirapex, Lexapro, Vyvanse, … president of Ionis Pharmaceuticals and chief medical officer of … Caplyta, an approved drug for the treatment of bipolar depression … the success of several biotechnology companies, including Juno …

  • Patients and regulators are at odds over Parkinson’s generic drugs 20 Sep 2023 05:32 GMT

    … bioequivalence test." After taking medicines for a long time, … complaints about Myung In Pharmaceutical';s generic drug Myungdopar, a generic … hydrochloride), Boehringer-Ingelheim's Mirapex (pramipexole hydrochloride monohydrate), and MSD…

Satisfied with the content?

Continue to create your account.